93 related articles for article (PubMed ID: 25909136)
1. [Histological subtypes of ovarian carcinoma and their importance for clinical prognosis].
Zlatkov V
Akush Ginekol (Sofiia); 2015; 54(2):19-23. PubMed ID: 25909136
[TBL] [Abstract][Full Text] [Related]
2. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
3. [Borderline ovarian tumours: a challenge for clinicians].
Nacheva A; Atanasova V; Miloshov V; Ganovska A; Simeonova C
Akush Ginekol (Sofiia); 2013; 52(3):27-30. PubMed ID: 24283059
[TBL] [Abstract][Full Text] [Related]
4. [Histologic classification and morphologic prognostic factors in malignant ovarian tumors].
Horn LC; Fricke K; Krugmann J
Zentralbl Gynakol; 1995; 117(7):335-45. PubMed ID: 7668062
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the expression of S100A1 protein in serous, mucinous and endometroid ovarian carcinoma].
Yordanov A; Ivanov I; Popovska S; Dineva T; Dimitrov T; Ivanova Z
Akush Ginekol (Sofiia); 2013; 52(5):22-6. PubMed ID: 24501865
[TBL] [Abstract][Full Text] [Related]
6. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
7. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
[TBL] [Abstract][Full Text] [Related]
9. Rare ovarian tumors: an update on diagnosis and treatment.
Debuquoy C; Romeo C; Vanacker H; Ray-Coquard I
Int J Gynecol Cancer; 2020 Jun; 30(6):879-887. PubMed ID: 32461259
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
11. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
12. Management of borderline tumors of the ovary: state of the art.
Tropé C; Kaern J
Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
[TBL] [Abstract][Full Text] [Related]
13. Histologic subtypes of ovarian carcinoma: an overview.
Soslow RA
Int J Gynecol Pathol; 2008 Apr; 27(2):161-74. PubMed ID: 18317227
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer: histogenetic classification, histologic grading, diagnosis, staging, and epidemiology.
Jolles CJ
Clin Obstet Gynecol; 1985 Dec; 28(4):787-99. PubMed ID: 3000668
[TBL] [Abstract][Full Text] [Related]
15. [Histological grading of epithelial ovarian cancer. Review and recommendation].
Hauptmann S; du Bois A; Meinhold-Herlein I; Pfisterer J; Avril S
Pathologe; 2014 Sep; 35(5):497-503. PubMed ID: 25069848
[TBL] [Abstract][Full Text] [Related]
16. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
Anglesio MS; Carey MS; Köbel M; Mackay H; Huntsman DG;
Gynecol Oncol; 2011 May; 121(2):407-15. PubMed ID: 21276610
[TBL] [Abstract][Full Text] [Related]
17. Distribution and case-fatality ratios by cell-type for ovarian carcinomas: a 22-year series of 562 patients with uniform current histological classification.
Seidman JD; Vang R; Ronnett BM; Yemelyanova A; Cosin JA
Gynecol Oncol; 2015 Feb; 136(2):336-40. PubMed ID: 25528497
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
[TBL] [Abstract][Full Text] [Related]
19. [Histologic type and tumor maturity as prognostic factors in malignant epithelial tumors of the ovary].
Jukić S; Ilić J; Krstulović B; Krznar B; Culig V
Jugosl Ginekol Perinatol; 1989; 29(3-4):137-9. PubMed ID: 2601368
[TBL] [Abstract][Full Text] [Related]
20. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
Schwartz DR; Kardia SL; Shedden KA; Kuick R; Michailidis G; Taylor JM; Misek DE; Wu R; Zhai Y; Darrah DM; Reed H; Ellenson LH; Giordano TJ; Fearon ER; Hanash SM; Cho KR
Cancer Res; 2002 Aug; 62(16):4722-9. PubMed ID: 12183431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
